Applied Microbiology and Biotechnology, Vol.105, No.11, 4649-4662, 2021
A screened PirB antagonist peptide antagonizes A beta(42)-mediated inhibition of neurite outgrowth in vitro
Alzheimer's disease (AD) is a type of progressive neurodegenerative disease, and amyloid beta-protein 42 (A beta(42)) serves an important role in the pathological process of development of AD. Paired immunoglobulin-like receptor B (PirB) is a functional receptor for myelin inhibitors of neuron regeneration in the CNS, and it has also been identified to function as a high-affinity receptor for A beta. Here, we used a phage display to identify a specific PirB antagonist peptide 11(PAP11, PFRLQLS), which could reverse A beta(42)-induced neurotoxicity and promote neurite outgrowth in vitro. Immunofluorescence analysis showed that PAP11 colocalized with PirB on the membrane of cortical neurons. Horseradish peroxidase-streptavidin-biotin assay further proved that PAP11 directly binds to PirB and the dissociation constant (K-d) was 0.128 mu M. PAP11 functionally antagonized the neurite outgrowth inhibitory effect induced by A beta(42) in cortical neurons, and the underlying mechanism was associated with a PirB-ROCK2/CRMP2 signaling pathway. The novel PirB antagonist peptide PAP11 may be a promising candidate therapeutic agent for the treatment of AD and other neurodegenerative diseases.